Study in Nature Medicine Shows Superior Outcomes for Patients in Leukemia & Lymphoma Society's Paradigm-Shifting Beat AML Clinical Trial
October 27, 2020
October 27, 2020
RYE BROOK, New York, Oct. 27 (TNSJou) -- The Leukemia and Lymphoma Society issued the following news release on Oct. 26:
Patients participating in The Leukemia & Lymphoma Society's (LLS) groundbreaking precision medicine Beat AML Master Clinical Trial had superior outcomes compared to acute myeloid leukemia (AML) patients who opted for standard chemotherapy treatment, according to findings published today in the prestigious Nature Medicine journal.
The Beat AML tria . . .
Patients participating in The Leukemia & Lymphoma Society's (LLS) groundbreaking precision medicine Beat AML Master Clinical Trial had superior outcomes compared to acute myeloid leukemia (AML) patients who opted for standard chemotherapy treatment, according to findings published today in the prestigious Nature Medicine journal.
The Beat AML tria . . .